Literature DB >> 24591377

IκBε is a key regulator of B cell expansion by providing negative feedback on cRel and RelA in a stimulus-specific manner.

Bryce N Alves1, Rachel Tsui, Jonathan Almaden, Maxim N Shokhirev, Jeremy Davis-Turak, Jessica Fujimoto, Harry Birnbaum, Julia Ponomarenko, Alexander Hoffmann.   

Abstract

The transcription factor NF-κB is a regulator of inflammatory and adaptive immune responses, yet only IκBα was shown to limit NF-κB activation and inflammatory responses. We investigated another negative feedback regulator, IκBε, in the regulation of B cell proliferation and survival. Loss of IκBε resulted in increased B cell proliferation and survival in response to both antigenic and innate stimulation. NF-κB activity was elevated during late-phase activation, but the dimer composition was stimulus specific. In response to IgM, cRel dimers were elevated in IκBε-deficient cells, yet in response to LPS, RelA dimers also were elevated. The corresponding dimer-specific sequences were found in the promoters of hyperactivated genes. Using a mathematical model of the NF-κB-signaling system in B cells, we demonstrated that kinetic considerations of IκB kinase-signaling input and IκBε's interactions with RelA- and cRel-specific dimers could account for this stimulus specificity. cRel is known to be the key regulator of B cell expansion. We found that the RelA-specific phenotype in LPS-stimulated cells was physiologically relevant: unbiased transcriptome profiling revealed that the inflammatory cytokine IL-6 was hyperactivated in IκBε(-/-) B cells. When IL-6R was blocked, LPS-responsive IκBε(-/-) B cell proliferation was reduced to near wild-type levels. Our results provide novel evidence for a critical role for immune-response functions of IκBε in B cells; it regulates proliferative capacity via at least two mechanisms involving cRel- and RelA-containing NF-κB dimers. This study illustrates the importance of kinetic considerations in understanding the functional specificity of negative-feedback regulators.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24591377      PMCID: PMC3965642          DOI: 10.4049/jimmunol.1302351

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  IkappaB family members function by different mechanisms.

Authors:  W F Tam; R Sen
Journal:  J Biol Chem       Date:  2001-01-10       Impact factor: 5.157

2.  IL-6 rescues the hyporesponsiveness of c-Rel deficient B cells independent of Bcl-xL, Mcl-1, and Bcl-2.

Authors:  Joseph R Tumang; Constance Y Hsia; Wenzhi Tian; Jacqueline F Bromberg; Hsiou-Chi Liou
Journal:  Cell Immunol       Date:  2002 May-Jun       Impact factor: 4.868

Review 3.  Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models.

Authors:  S Gerondakis; R Grumont; R Gugasyan; L Wong; I Isomura; W Ho; A Banerjee
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

4.  Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes.

Authors:  N Burdin; C Van Kooten; L Galibert; J S Abrams; J Wijdenes; J Banchereau; F Rousset
Journal:  J Immunol       Date:  1995-03-15       Impact factor: 5.422

5.  IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice.

Authors:  J F Klement; N R Rice; B D Car; S J Abbondanzo; G D Powers; P H Bhatt; C H Chen; C A Rosen; C L Stewart
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

6.  Human interleukin-6 is in vivo an autocrine growth factor for human herpesvirus-8-infected malignant B lymphocytes.

Authors:  A Foussat; J Wijdenes; L Bouchet; G Gaidano; F Neipel; K Balabanian; P Galanaud; J Couderc; D Emilie
Journal:  Eur Cytokine Netw       Date:  1999-12       Impact factor: 2.737

7.  Cloning and functional characterization of mouse IkappaBepsilon.

Authors:  S Simeonidis; S Liang; G Chen; D Thanos
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

Review 8.  Role of INTERLEUKIN-6 in the pathogenesis of multiple myeloma.

Authors:  K Gadó; G Domján; H Hegyesi; A Falus
Journal:  Cell Biol Int       Date:  2000       Impact factor: 3.612

9.  The subunit composition of NF-kappa B complexes changes during B-cell development.

Authors:  R J Grumont; S Gerondakis
Journal:  Cell Growth Differ       Date:  1994-12

10.  NF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses.

Authors:  T S Doi; T Takahashi; O Taguchi; T Azuma; Y Obata
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

View more
  25 in total

Review 1.  The molecular pathogenesis of chronic lymphocytic leukaemia.

Authors:  Giulia Fabbri; Riccardo Dalla-Favera
Journal:  Nat Rev Cancer       Date:  2016-03       Impact factor: 60.716

Review 2.  A review of quantitative modeling of B cell responses to antigenic challenge.

Authors:  Timothy P Hickling; Xiaoying Chen; Paolo Vicini; Satyaprakash Nayak
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-10-19       Impact factor: 2.745

3.  A Regulatory Circuit Controlling the Dynamics of NFκB cRel Transitions B Cells from Proliferation to Plasma Cell Differentiation.

Authors:  Koushik Roy; Simon Mitchell; Yi Liu; Sho Ohta; Yu-Sheng Lin; Marie Oliver Metzig; Stephen L Nutt; Alexander Hoffmann
Journal:  Immunity       Date:  2019-03-05       Impact factor: 31.745

4.  Nongenetic origins of cell-to-cell variability in B lymphocyte proliferation.

Authors:  Simon Mitchell; Koushik Roy; Thomas A Zangle; Alexander Hoffmann
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-07       Impact factor: 11.205

Review 5.  Limiting inflammation-the negative regulation of NF-κB and the NLRP3 inflammasome.

Authors:  Inna S Afonina; Zhenyu Zhong; Michael Karin; Rudi Beyaert
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

Review 6.  Mechanisms of Phytonutrient Modulation of Cyclooxygenase-2 (COX-2) and Inflammation Related to Cancer.

Authors:  Shreena J Desai; Ben Prickril; Avraham Rasooly
Journal:  Nutr Cancer       Date:  2018-03-26       Impact factor: 2.900

7.  Exclusivity and Compensation in NFκB Dimer Distributions and IκB Inhibition.

Authors:  Kristen M Ramsey; Wei Chen; James D Marion; Simon Bergqvist; Elizabeth A Komives
Journal:  Biochemistry       Date:  2019-05-14       Impact factor: 3.162

8.  Iterative Modeling Reveals Evidence of Sequential Transcriptional Control Mechanisms.

Authors:  Christine S Cheng; Marcelo S Behar; Gajendra W Suryawanshi; Kristyn E Feldman; Roberto Spreafico; Alexander Hoffmann
Journal:  Cell Syst       Date:  2017-02-22       Impact factor: 10.304

9.  B-cell survival and development controlled by the coordination of NF-κB family members RelB and cRel.

Authors:  Jonathan V Almaden; Yi C Liu; Edward Yang; Dennis C Otero; Harry Birnbaum; Jeremy Davis-Turak; Masataka Asagiri; Michael David; Ananda W Goldrath; Alexander Hoffmann
Journal:  Blood       Date:  2016-01-14       Impact factor: 22.113

10.  Eleven loci with new reproducible genetic associations with allergic disease risk.

Authors:  Manuel A R Ferreira; Judith M Vonk; Hansjörg Baurecht; Ingo Marenholz; Chao Tian; Joshua D Hoffman; Quinta Helmer; Annika Tillander; Vilhelmina Ullemar; Yi Lu; Franz Rüschendorf; David A Hinds; Norbert Hübner; Stephan Weidinger; Patrik K E Magnusson; Eric Jorgenson; Young-Ae Lee; Dorret I Boomsma; Robert Karlsson; Catarina Almqvist; Gerard H Koppelman; Lavinia Paternoster
Journal:  J Allergy Clin Immunol       Date:  2018-04-19       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.